---
schema_version: "secwatch.filing_event.v1"
accession: "0001764013-25-000007"
form_type: "8-K"
ticker: "IMVT"
cik: "0001764013"
company_name: "Immunovant, Inc."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:42:15.335707+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Immunovant announces $450M PIPE at $20/share to advance pipeline

## Summary
- Agreed to sell 22.5M shares at $20/share to three institutional investors, including Roivant Sciences.
- Gross proceeds expected ~$450M; closing on or about Jan 15, 2025 subject to customary conditions.
- Proceeds to fund development pipeline (lead asset IMVT-1402), working capital, and general corporate purposes.
- Shares sold in private placement exempt from registration; resale registration to be filed with SEC.

## SEC filing metadata
- accession: 0001764013-25-000007
- form_type: 8-K
- ticker: IMVT
- cik: 0001764013
- company_name: Immunovant, Inc.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1764013/000176401325000007/0001764013-25-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1764013/000176401325000007/imvt-20250113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001764013-25-000007
- JSON: https://secwatch.observer/filing/0001764013-25-000007.json
- Plain text: https://secwatch.observer/filing/0001764013-25-000007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.